In mouse models and in humans with active pulmonary tuberculosis, both IL-17- and IL-22-producing CD4+ T cells and IL-17+γδ T cells were shown to contribute to the antimycobacterial immune response [21, 22]. This evidence concerns the gene CD4 and pulmonary tuberculosis.